Haupt M T, Teerapong P, Green D, Schaeffer R C, Carlson R W
Circ Shock. 1984;12(3):213-24.
Physiologic effects of colloidal (5% albumin, 6% hydroxyethylstarch, 6% dextran-70) and crystalloidal (Ringer's lactate) fluids were examined in rats (six in each fluid group) after infusion of an LD99 of rattlesnake venom, previously shown to produce shock secondary to increased vascular permeability. Venom infusion (iv, 2.0 mg/kg, 30 min) was followed by fluid infusion (iv, 30 min) in quantities sufficient to reverse venom-induced hemoconcentration. Venom infusion decreased mean arterial pressure, increased blood lactate, and increased hematocrit in all animals (p less than .01). Fluid infusion reversed these changes, although six times the volume of crystalloid was required to produce hemodilution comparable to the colloidal fluids (120 ml/kg Ringer's lactate, 20 ml/kg colloids). Although no significant changes in the respiratory parameters were noted after administration of the three colloids, Ringer's lactate produced decreases in PaC2 (107 +/- 6 torr, mean +/- SEM to 72 +/- 7, p less than .05), increases in PaCO2 (30 +/- 4 torr to 55 +/- 5, P less than .001), decreases in plasma colloid osmotic pressure (14.2 +/- 0.8 torr to 6.6 +/- 0.9, p less than .001) at the end of fluid infusion. These changes were associated with significantly increased wet-dry lung ratios (p less than .001) in identically prepared animals, sacrificed after fluid infusion. In spite of the development of pulmonary edema in the crystalloid-treated animals, survival was similar for each group (6/6 for albumin and dextran, 5/6 for hydroxyethylstarch and Ringer's lactate). We thus conclude that both colloidal and crystalloidal fluid resuscitation leads to survival in permeability shock. Resuscitation with crystalloidal fluid, however, requires significantly greater volumes and is associated with the development of pulmonary edema.
在大鼠(每组6只)中,静脉注射致死剂量99%的响尾蛇毒液(先前已证明该毒液可因血管通透性增加而导致休克)后,研究了胶体液(5%白蛋白、6%羟乙基淀粉、6%右旋糖酐-70)和晶体液(乳酸林格氏液)的生理效应。在静脉注射毒液(2.0mg/kg,30分钟)后,接着静脉输注足量液体(30分钟)以逆转毒液引起的血液浓缩。静脉注射毒液使所有动物的平均动脉压降低、血乳酸增加、血细胞比容升高(p<0.01)。液体输注逆转了这些变化,尽管需要6倍于晶体液的量才能产生与胶体液相当的血液稀释效果(120ml/kg乳酸林格氏液,20ml/kg胶体液)。尽管给予三种胶体液后呼吸参数无显著变化,但输注乳酸林格氏液后,动脉血氧分压(PaO₂)降低(从107±6托降至72±7,p<0.05),动脉血二氧化碳分压(PaCO₂)升高(从30±4托升至55±5,p<0.001),液体输注结束时血浆胶体渗透压降低(从14.2±0.8托降至6.6±0.9,p<0.001)。这些变化与在液体输注后处死的相同制备动物的肺湿干比显著增加(p<0.001)相关。尽管晶体液治疗的动物出现了肺水肿,但每组的存活率相似(白蛋白和右旋糖酐组为6/6,羟乙基淀粉和乳酸林格氏液组为5/6)。因此,我们得出结论,胶体液和晶体液复苏均可使通透性休克患者存活。然而,晶体液复苏需要更大的量,且与肺水肿的发生有关。